Please check your internet connection and try again.
# Dexamethasone in Chronic ITP
## Overview
Dexamethasone is a potent synthetic glucocorticoid used in Immune Thrombocytopenia (ITP) for its rapid onset of action and immunosuppressive effects. It is often preferred over prednisone for first-line treatment due to faster platelet recovery and a shorter duration of therapy.
## Primary Indications
* First-line induction therapy for newly diagnosed ITP.
* Management of acute exacerbations in chronic ITP.
## Adult Dosing
* **Standard Regimen:** 40 mg orally once daily for 4 consecutive days.
* **Cycling:** Courses may be repeated every 14–28 days depending on clinical response, though chronic long-term maintenance with high-dose dexamethasone is generally avoided due to toxicity.
## Pediatric Dosing
* **Standard Regimen:** 0.6 mg/kg/day (maximum 40 mg/day) orally once daily for 4 consecutive days.
* **Note:** Dosing may vary by institutional protocol. Consult local pediatric hematology/oncology guidelines.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No standard dose reduction required for short-term pulse therapy; however, monitor for fluid retention and glucose intolerance.
* **Elderly:** Use caution; consider dose reduction if significant comorbidities (hypertension, diabetes) exist.
## Contraindications
* Systemic fungal infections.
* Known hypersensitivity to dexamethasone or components of the formulation.
* Avoid live or live-attenuated vaccines during high-dose therapy.
## Adverse Effects
* **Common:** Insomnia, mood changes, hyperglycemia, increased appetite, fluid retention/edema.
* **Serious:** GI bleeding, infection, hypertension, avascular necrosis (primarily with prolonged use), and osteoporosis.
## Key Drug Interactions
* **CYP3A4 Inducers:** (e.g., phenytoin, carbamazepine, rifampin) may decrease dexamethasone efficacy.
* **NSAIDs:** Increased risk of GI ulceration and bleeding (use with extreme caution in thrombocytopenic patients).
* **Antidiabetic Agents:** Dexamethasone may antagonize hypoglycemic effects; insulin requirements may increase significantly.
* **Warfarin/Anticoagulants:** May alter INR; monitor closely if concomitant use is required.
## Monitoring
* **Platelet counts:** Baseline and periodic monitoring to assess response (usually increases within 4–14 days).
* **Blood Glucose:** Monitor for steroid-induced hyperglycemia.
* **Blood Pressure:** Regular monitoring during the 4-day cycle.
* **GI Health:** Observe for signs of occult bleeding (melena, hematemesis).
## Clinical Pearls
* **Efficacy:** Many experts consider high-dose dexamethasone superior to standard-dose prednisone because it induces a faster initial platelet rise.
* **GI Protection:** Consider H2-blockers or PPIs for patients with a history of peptic ulcer disease.
* **Tapering:** Short courses (4 days) typically do not require a formal taper, but prolonged use necessitates a gradual taper to prevent adrenal insufficiency.
* **Psychiatric:** Counsel patients on potential mood swings, irritability, and sleep disturbances, which are common with high-dose pulses.
***
**Educational Disclaimer:** This information is intended for educational purposes for healthcare professionals. Clinical protocols vary by institution. Always verify current prescribing information, laboratory values, and patient-specific contraindications via official drug monographs (e.g., Lexicomp, Micromedex) or institutional guidelines before prescribing.
